THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 108 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,000 | +22.1% | 9,567 | +46.5% | 0.00% | – |
| Q2 2023 | $68,000 | +28.3% | 6,532 | +33.8% | 0.00% | – |
| Q1 2023 | $53,000 | -56.9% | 4,883 | -55.4% | 0.00% | – |
| Q4 2022 | $123,000 | +83.6% | 10,953 | +65.7% | 0.00% | – |
| Q3 2022 | $67,000 | +1575.0% | 6,610 | +1330.7% | 0.00% | – |
| Q2 2022 | $4,000 | -96.8% | 462 | -96.5% | 0.00% | – |
| Q1 2022 | $124,000 | -54.9% | 13,032 | -47.5% | 0.00% | – |
| Q4 2021 | $275,000 | +75.2% | 24,836 | +17.6% | 0.00% | – |
| Q3 2021 | $157,000 | -56.9% | 21,113 | -15.7% | 0.00% | – |
| Q2 2021 | $364,000 | -16.5% | 25,056 | +17.4% | 0.00% | – |
| Q1 2021 | $436,000 | +10.9% | 21,345 | -3.6% | 0.00% | – |
| Q4 2020 | $393,000 | +16.6% | 22,136 | -2.7% | 0.00% | – |
| Q3 2020 | $337,000 | -34.3% | 22,758 | -7.1% | 0.00% | – |
| Q2 2020 | $513,000 | -11.6% | 24,486 | -2.4% | 0.00% | – |
| Q1 2020 | $580,000 | -5.5% | 25,081 | +5.8% | 0.00% | – |
| Q4 2019 | $614,000 | +60.7% | 23,716 | +21.0% | 0.00% | – |
| Q3 2019 | $382,000 | +25.2% | 19,602 | +4.9% | 0.00% | – |
| Q2 2019 | $305,000 | -26.9% | 18,692 | +1.7% | 0.00% | – |
| Q1 2019 | $417,000 | -9.3% | 18,374 | +2.2% | 0.00% | – |
| Q4 2018 | $460,000 | -24.5% | 17,978 | -3.5% | 0.00% | – |
| Q3 2018 | $609,000 | +51.1% | 18,632 | +5.0% | 0.00% | – |
| Q2 2018 | $403,000 | -0.2% | 17,750 | +6.5% | 0.00% | – |
| Q1 2018 | $404,000 | +6.3% | 16,664 | +22.3% | 0.00% | – |
| Q4 2017 | $380,000 | -29.0% | 13,622 | -12.9% | 0.00% | – |
| Q3 2017 | $535,000 | +37.2% | 15,632 | +59.7% | 0.00% | – |
| Q2 2017 | $390,000 | +1.3% | 9,789 | -6.4% | 0.00% | – |
| Q1 2017 | $385,000 | -0.8% | 10,456 | -14.1% | 0.00% | – |
| Q4 2016 | $388,000 | -50.7% | 12,179 | -43.9% | 0.00% | – |
| Q3 2016 | $787,000 | +239.2% | 21,715 | +112.7% | 0.00% | – |
| Q2 2016 | $232,000 | -88.6% | 10,210 | -90.6% | 0.00% | -100.0% |
| Q1 2016 | $2,035,000 | +1083.1% | 108,287 | +932.6% | 0.00% | – |
| Q4 2015 | $172,000 | +48.3% | 10,487 | -0.3% | 0.00% | – |
| Q3 2015 | $116,000 | -15.3% | 10,515 | 0.0% | 0.00% | – |
| Q2 2015 | $137,000 | +1270.0% | 10,515 | +1643.8% | 0.00% | – |
| Q1 2015 | $10,000 | -44.4% | 603 | -50.8% | 0.00% | – |
| Q4 2014 | $18,000 | -92.9% | 1,226 | -88.9% | 0.00% | – |
| Q3 2014 | $255,000 | +844.4% | 11,094 | +1203.6% | 0.00% | – |
| Q2 2014 | $27,000 | – | 851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |